Lena Stigh Project Manager Jegrelius Institute for Applied Green - - PowerPoint PPT Presentation

lena stigh
SMART_READER_LITE
LIVE PREVIEW

Lena Stigh Project Manager Jegrelius Institute for Applied Green - - PowerPoint PPT Presentation

Lena Stigh Project Manager Jegrelius Institute for Applied Green Chemistry What are the challenges? Essential product The blood bag is a life-saving product Transfusion of blood is a transfer of living blood cells (or plasma) involving


slide-1
SLIDE 1

Lena Stigh

Project Manager Jegrelius Institute for Applied Green Chemistry

slide-2
SLIDE 2

What are the challenges?

slide-3
SLIDE 3

Essential product

  • The blood bag is a life-saving product
  • Transfusion of blood is a transfer of living blood

cells (or plasma) involving potentially immunological effects and effects associated with physiologically active substances. Those effects are considered to pose a significantly higher risk to the patient.

slide-4
SLIDE 4
  • The red blood cells are stabilized by

DEHP causing less hemolysis

  • International norms; max 0,8% hemolysis

We need to store blood

slide-5
SLIDE 5
  • The blood bag is a complex product
  • Quality requirements on blood components
  • High material properties required

Centrifugation Sterile sealable tubings Storage at low temperature up to 37 C Compatibility Technical barriers

slide-6
SLIDE 6

Economic barriers

  • “Not profitable for the producers”
  • Investments and long lead times
  • Lack of life cycle perspective
  • A risk of higher initial cost
slide-7
SLIDE 7

Lack of clear demand

  • The incentives for the manufactures

to bring new blood bags to the market are not high enough

  • Legislation not strong enough
slide-8
SLIDE 8

How do we

  • vercome these

challenges?

slide-9
SLIDE 9
slide-10
SLIDE 10

To show that it is possible to produce a PVC-free blood bag that fulfil requirement specification, including CE-labelling To cooperate with European healthcare to disseminate knowledge and increase the demand Objectives

slide-11
SLIDE 11

How far have we come ?

slide-12
SLIDE 12
slide-13
SLIDE 13
slide-14
SLIDE 14

Next to come

  • User tests
  • A non-PVC blood bag tested
  • Technical Report/Publication
  • Economic feasibility study
  • LCA of the new bag
  • Final Workshops
  • End of project 30 March 2017
slide-15
SLIDE 15

How about increased awareness and demand ?

slide-16
SLIDE 16

If a PVC free blood bag were available… Would you buy it?

slide-17
SLIDE 17

A bag that…

  • minimise patient exposure to potentially

hazardous substances and thus gives long- term health improvements

  • gives better working environment for both

manufacturers and hospital employees

  • reduces long-term costs in healthcare due to

healthier population

slide-18
SLIDE 18

You will find the petition on the website.